Advertisement

Cytokines in Severe Head Injury

  • Linda Ott
  • Craig McClain
  • Stephen Scheff
  • Jimmi Hatton
  • Byron Young
Chapter
Part of the Contemporary Neuroscience book series (CNEURO)

Abstract

During the 1970s and early 1980s the morbidity and mortality rate from severe head injury significantly decreased. There still are patients who succumb to this severe injury or survive with poor recovery. Currently, about 30% survive with poor recovery, and this rate of poor outcome has not significantly changed during the past decade (1). In an effort to improve the outcome further, investigators have started to study intensively the type of damage inflicted by secondary factors that lead to secondary injury, and those caused by systemic effects of brain injury. Factors that block these negative effects are being developed and studied in an attempt to improve patient outcome. It is our hypothesis that cytokines play an important role in the metabolic response to head injury and that medical intervention that modulates the cytokine response may improve the adverse metabolic effects of head injury. The present chapter focuses on the role of cytokines in the metabolic response to head injury. Specifically, we will present evidence for increased cytokine levels and biologic effects following clinical and experimental brain injury. We will show that cytokine infusion mimics the systemic response to brain injury, and we will discuss potential roles of cytokine modulation following brain injury.

Keywords

Gastric Emptying Head Injury Severe Head Injury Serum Zinc Level Tumour Necrosis Factor Level 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Marshall, L. F., Gautille, T., Klauber, M. R., Eisenberg, H. M., Jane, J. A., Leurssen, T. G., Marmarou, A., and Foulkes, M. A. (1991) The outcome of severe closed head injury. J. Neurosurg. 75, S28 - S36.Google Scholar
  2. 2.
    Chiolero, R., Schutz, Y., Lemerchand, T., Felber, J. P., de Tribolet, N., Freeman, J., and Jequier, E. (1989) Hormonal and metabolic changes following severe head injury or noncranial injury. JPEN J. Parenter. Enteral Nutr. 13, 5–12.PubMedCrossRefGoogle Scholar
  3. 3.
    Clifton, G. L., Ziegler, M. G., and Grossman, R. G. (1981) Circulating catecholamines and sympathetic activity after head injury. Neurosurgery 8, 10–13.PubMedCrossRefGoogle Scholar
  4. 4.
    Hadfield, J. M., Little, R. A., and Jones, R. A. (1992) Measured energy expenditure and plasma substrate and hormonal changes after severe head injury. Injury 23, 177–182.PubMedCrossRefGoogle Scholar
  5. 5.
    McClain, C. J., Twyman, D. L., Ott, L. G., Rapp, R. P., Tibbs, P. A., Norton, J. A., Kasarskis, E. J., Dempsey, R. J., and Young, B. (1986) Serum and urine zinc response in head-injured patients. J. Neurosurg. 64, 224–230.PubMedCrossRefGoogle Scholar
  6. 6.
    Robertson, C. S., Clifton, C. L., and Grossman, R. G. (1984) Oxygen utilization and cardiovascular function in head-injured patients. Neurosurgery 15, 307–314.PubMedCrossRefGoogle Scholar
  7. 7.
    Young, B., Ott, L., Norton, J., Tibbs, P., Rapp, R., McClain, C., and Dempsey, R. (1985) Metabolic and nutritional sequela of the non-steroid treated head injury patient. Neurosurgery 17, 784–791.PubMedCrossRefGoogle Scholar
  8. 8.
    Young, A. B., Ott, L. G., Beard, D., Dempsey, R. J., Tibbs, P. A., and McClain, C. J. (1988) The acute-phase response of the brain-injured patient. J. Neurosurg. 69, 375–380.PubMedCrossRefGoogle Scholar
  9. 9.
    Young, B., Ott, L., Phillips, R., and McClain, C. (1991) Metabolic management of the patient with head injury. Neurosurg. Clin. North Am. 2, 301–320.Google Scholar
  10. 10.
    Beutler, B. and Cerami, A. (1987) Cachectin: more than a tumor necrosis factor. N. Engl. J. Med. 316, 379–385.PubMedCrossRefGoogle Scholar
  11. 11.
    DeForge, L. E., Nguyen, D. T., Kunkel, S. L., and Remick, D. G. (1990) Regulation of the pathophysiology of tumor necrosis factor. J. Lab. Clin. Med. 116, 429–438.PubMedGoogle Scholar
  12. 12.
    Dinarello, C. A. (1988) Biology of interleukin 1. FASEB J. 2, 108–115.PubMedGoogle Scholar
  13. 13.
    Dinarello, C. A. and Neta, R. (1989) An overview of interleukin-1 as a therapeutic agent. Biotherapy 1, 245–254.PubMedCrossRefGoogle Scholar
  14. 14.
    Gauldie, J., Sauder, D. N., McAdam, K. P., and Dinarello, C. A. (1987) Purified interleukin-1 (IL-1) from human monocytes stimulates acute-phase protein synthesis by rodent hepatocytes in vitro. Immunology 60, 203–207.PubMedGoogle Scholar
  15. 15.
    Dinarello, C. A. (1991) The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome. J. Infect. Dis. 163, 1177–1184.PubMedCrossRefGoogle Scholar
  16. 16.
    Akira, S., Hirano, R., Taga, R., and Kishimoto, T. (1990) Biology of multifunctional cytokines: IL-6 and related molecules (IL-1 and TNF). FASEB J. 4, 2860–2867.PubMedGoogle Scholar
  17. 17.
    Le, J. and Vilcek, J. (1987) Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. Lab. Invest. 56, 234–248.Google Scholar
  18. 18.
    McClain, C. J., Cohen, D., Ott, L., Dinarello, C. A., and Young, B. (1987) Ventricular fluid interleukin-1 activity in patients with head injury. J. Lab. Clin. Med. 110, 48–54.PubMedGoogle Scholar
  19. 19.
    McClain, C., Cohen, D., Phillips, R., Ott, L., and Young, B. (1991) Increased plasma and ventricular fluid interleukin-6 levels in patients with head injury. J. Lab. Clin. Med. 118, 225–231.PubMedGoogle Scholar
  20. 20.
    Kossmann, T., Hans, V., Imhof, H. G., Trentz, O., and Morganti-Kossmann, M. C. (1996) Interleukin-6 released in human cerebrospinal fluid following traumatic brain injury may trigger nerve growth factor production in astrocytes. Brain Res. 713, 143–152.PubMedCrossRefGoogle Scholar
  21. 21.
    Goodman, J. C., Robertson, C. S., Grossman, R. G., and Narayan, R. K. (1990) Elevation of tumor necrosis factor in head injury. J. Neuroimmunol. 30, 213–217.PubMedCrossRefGoogle Scholar
  22. 22.
    Griffin, W. S., Sheng, J. G., Gentleman, S. M., Graham, D. I., Mrak, R. E., and Roberts, G. W. (1994) Microglial interleukin-1 alpha expression in human head injury: correlations with neuronal and neuritic beta-amyloid precursor protein expression. Neurosci. Lett. 176, 133–136.Google Scholar
  23. 23.
    Giulian, D. and Lachman, L. B. (1985) Interleukin-1 stimulation of astroglial proliferation after brain injury. Science 228, 497–499.PubMedCrossRefGoogle Scholar
  24. 24.
    Ban, E., Haour, F., and Lenstra, R. (1992) Brain interleukin 1 gene expression induced by peripheral lipopolysaccharide administration. Cytokine 4, 48–54.PubMedCrossRefGoogle Scholar
  25. 25.
    Shohami, E., Novikov, M., Bass, R., Yamin, A., Gallily, R. (1994) Closed head injury triggers early production of TNF alpha and IL-6 by brain tissue. J. Cereb. Blood Flow Metab. 14, 615–619.PubMedCrossRefGoogle Scholar
  26. 26.
    Nieto-Sampedro, M. and Berman, M. A. (1987) Interleukin-1-like activity in rat brain: sources, targets, and effect of injury. J. Neurosci. Res. 17, 214–219.PubMedCrossRefGoogle Scholar
  27. 27.
    Taupin, V., Toulmond, S., Serrano, A., Benavides, J., and Zavala, F. (1993) Increase in IL-6, IL-1 and TNF levels in rat brain following traumatic lesion. Influence of pre-and post-traumatic treatment with Ro5 4864, a peripheral-type (p site) benzodiazepine ligand. J. Neuroimmunol. 42, 177–185.PubMedCrossRefGoogle Scholar
  28. 28.
    Yan, H. Q., Banos, M. A., Herregodts, P., Hooghe, R., and Hooghe-Peters, E. L. (1992) Expression of interleukin (IL)-1 beta, IL-6 and their respective receptors in the normal rat brain and after injury. Eur. J. Immunol. 22, 2963–2971.PubMedCrossRefGoogle Scholar
  29. 29.
    Morganti-Kossmann, M. C., Kossmann, T., and Wahl, S. M. (1992) Cytokines and neuropathology. Trends Pharmacol. Sci. 13, 286–291.PubMedCrossRefGoogle Scholar
  30. 30.
    Halstensen, A., Ceska, M., Brandtzaeg, P., Redl, H., Naess, A., and Waage, A. (1993) Interleukin-8 in serum and cerebrospinal fluid from patients with meningococcal disease. J. Infect. Dis. 167, 471–475.PubMedCrossRefGoogle Scholar
  31. 31.
    Cacabelos, R., Barquero, M., Garcia, P., Alvarez, X. A., and Varela de Seijas, E. (1991) Cerebrospinal fluid interleukin-1 beta (IL-1 beta) in Alzheimer’s disease and neurological disorders. Methods Find. Exp. Clin. Pharmacol. 13, 455–458.PubMedGoogle Scholar
  32. 32.
    Frei, K., Nadal, D., and Fontana, A. (1990) Intracerebral synthesis of tumor necrosis factor-alpha and interleukin-6 in infectious meningitis. Ann. NY Acad. Sci. 594, 326–335.PubMedCrossRefGoogle Scholar
  33. 33.
    Lieberman, A. P., Pitha, P. M., Shin, H. S., and Shin, M. L. (1989) Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. Proc. Natl. Acad. Sci. USA 86, 6348–6352.PubMedCrossRefGoogle Scholar
  34. 34.
    Symons, J. A., Bundick, R. V., Suckling, A. J., and Rumsby, M. G. (1987) Cerebrospinal fluid interleukin 1 like activity during chronic relapsing experimental allergic encephalomyelitis. Clin. Exp. Immunol. 68, 648–654.PubMedGoogle Scholar
  35. 35.
    Benveniste, E. N., Sparacio, S. M., Norris, J. G., Grenett, H. E., and Fuller, G. M. (1990) Induction and regulation of interleukin-6 gene expression in rat astrocytes. J. Neuroimmunol. 30, 201–212.PubMedCrossRefGoogle Scholar
  36. 36.
    Chiang, C. S. and McBride, W. H. (1991) Radiation enhances tumor necrosis factor alpha production by murine brain cells. Brain Res. 566, 265–269.PubMedCrossRefGoogle Scholar
  37. 37.
    Martin, F. C., Charles, A. C., Sanderson, M. J., and Merrill, J. E. (1992) Substance P stimulates IL-1 production by astrocytes via intracellular calcium. Brain Res. 18, 13–18.CrossRefGoogle Scholar
  38. 38.
    Minami, M., Kuraishi, Y., and Satoh, M. (1991) Effects of kainic acid on messenger RNA levels of IL-1 beta, IL-6, TNF alpha and LIF in the rat brain. Biochem. Biophys. Res. Commun. 176, 593–598.PubMedCrossRefGoogle Scholar
  39. 39.
    Schobitz, B., Van Den Dobbelsteen, M., Holsboer, F., Sutanto, W., and De Kloet, E. R. (1993) Regulation of interleukin 6 gene expression in rat. Endocrinology 132, 1569–1576.PubMedCrossRefGoogle Scholar
  40. 40.
    Woodroofe, M. N., Sarna, G. S., Wadhwa, M., Hayes, G. M., Loughlin, A. J., Tinker, A., and Cuzner, M. L. (1991) Detection of interleukin-1 and interleukin-6 in adult rat brain, following mechanical injury, by in vivo microdialysis: evidence for a role for microglia in cytokine production. J. Neuroimmunol. 33, 227–236.PubMedCrossRefGoogle Scholar
  41. 41.
    Woodroofe, M. N. (1995) Cytokine production in the central nervous system. Neurology 45, S6 - S10.PubMedCrossRefGoogle Scholar
  42. 42.
    Gadient, R. A., Cron, K. C., and Otten, U. (1990) Interleukin-1 beta and tumor necrosis factor-alpha synergistically stimulate nerve growth factor (NGF) release from cultured rat astrocytes. Neurosci. Lett. 117, 335–340.PubMedCrossRefGoogle Scholar
  43. 43.
    Mattson, M. P. and Scheff, S. W. (1994) Endogenous neuroprotection factors and traumatic brain injury: mechanisms of action and implications for therapy. J. Neuro-trauma 11, 3–33.Google Scholar
  44. 44.
    Selmaj, K. W., Farooq, M., Norton, W. T., Raine, C. S., and Brosnan, C. F. (1990) Proliferation of astrocytes in vitro in response to cytokines. J. Immunol. 144, 129–135.PubMedGoogle Scholar
  45. 45.
    Arvin, B., Neville, L. F., Barone, F. C., and Feurtstein, G. Z. (1995) Brain injury and inflammation. A putative role of TNF alpha. Ann. NY Acad. Sci. 765, 62–71.PubMedCrossRefGoogle Scholar
  46. 46.
    Gatti, S. and Bartfai, T. (1993) Induction of tumor necrosis factor-alpha mRNA in the brain after peripheral endotoxin treatment: comparison with interleukin-1 family and interleukin-6. Brain Res. 624, 291–294.PubMedCrossRefGoogle Scholar
  47. 47.
    Ando, M., Takashima, S., and Mito, T. (1988) Endotoxin, cerebral blood flow, amino acids and brain damage in young rabbits. Brain Dev. 10, 365–370.PubMedCrossRefGoogle Scholar
  48. 48.
    Terada, L. S., Willingham, I. R., Guidot, D. M., Shibao, G. N., Kindt, G. W., and Repine, J. E. (1992) Tungsten treatment prevents tumor necrosis factor-induced injury of brain endothelial cells. Inflammation 16, 13–19.PubMedCrossRefGoogle Scholar
  49. 49.
    Megyeri, P., Abraham, C. S., Temesvari, P., Kovacs, J., Vas, T., and Speer, C. P. (1992) Recombinant human tumor necrosis factor alpha constricts pial arterioles and increases blood-brain barrier permeability in newborn piglets. Neurosci. Lett. 148, 137–140.PubMedCrossRefGoogle Scholar
  50. 50.
    Komaki, G., Arimura, A., and Koves, K. (1992) Effect of intravenous injection of IL-1 beta on PGE2 levels in several brain areas as determined by microdialysis. Am. J. Physiol. 262, E246 - E251.PubMedGoogle Scholar
  51. 51.
    Shibata, M., Leffler, C. W., and Busija, D. W. (1990) Recombinant human interleukin 1 alpha dilates pial arterioles and increases cerebrospinal fluid prostanoids in piglets. Am. J. Physiol. 259, H1486 - H1491.PubMedGoogle Scholar
  52. 52.
    Gordon, C. R., Merchant, R. S., Marmarou, A., Rice, C. D., Marsh, J. T., and Young, H. F. (1990) Effect of murine recombinant interleukin-1 on brain oedema in the rat. Acta Neurochir. Suppl. (Wien.) 51, 268–270.Google Scholar
  53. 53.
    Toulmond, S. and Rothwell, N. J. (1995) Interleukin-1 receptor antagonist inhibits neuronal damage caused by fluid percussion injury in the rat. Brain Res. 671, 261–266.PubMedCrossRefGoogle Scholar
  54. 54.
    Kao, T. Y., Chio, C. C., and Lin, M. T. (1994) Hypothalamic dopamine release and local cerebral blood flow during onset of heatstroke in rats. Stroke 25, 2483–2487.PubMedCrossRefGoogle Scholar
  55. 55.
    Relton, J. K. and Rothwell, N. J. (1992) Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat. Brain Res. Bull. 29, 243–246.PubMedCrossRefGoogle Scholar
  56. 56.
    Ott, L., Young, B., Phillips, R., McClain, C. J., Adams, L., Dempsey, R., Tibbs, P., and Ryo, U. Y. (1991) Altered gastric emptying in the head-injured patient: relationship to feeding intolerance. J. Neurosurg. 74, 738–742.Google Scholar
  57. 57.
    Wingate, D. L. (1985) The brain-gut link. Viewpoints Dig. Dis. 17, 17–20.Google Scholar
  58. 58.
    Bresalier, R. S. (1990) Prophylaxis of stress-related gastric mucosal hemorrhage: a critical appraisal. J. Intensive Care Med. 5, 5–6.CrossRefGoogle Scholar
  59. 59.
    Peura, D. A. and Johnson, L. F. (1985) Cimetidine for prevention and treatment of gastroduodenal mucosal lesions in patients in an intensive care unit. Ann. Intern. Med. 103, 173–177.PubMedGoogle Scholar
  60. 60.
    Tracey, K. J., Beutler, B., Lowry, S. F., Merryweather, J., Wolpe, S., Milsark, I. W., Hariri, R. J., Fahey, T. J., III, Zentella, A., Albert, J. D., Shires, T., and Cerami, A. (1986) Shock and tissue injury induced by recombinant human cachectin. Science 234, 470–474.PubMedCrossRefGoogle Scholar
  61. 61.
    Tracey, K. J., Lowry, S. F., Fahey, T. J., III, Albert, J. D., Fong, Y., Hesse, D., Beutler, B., Manogue, K. R., Calvano, S., Wei, H., Cerami, A., and Shires, T. (1987) Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog. Surg. Gynecol. Obstet. 164, 415–422.Google Scholar
  62. 62.
    Andersen, L. W., Landow, L., Baek, L., Jansen, E., and Baker, S. (1993) Association between gastric intramucosal pH and splanchnic endotoxin, antibody to endotoxin, and tumor necrosis factor-alpha concentrations in patients undergoing cardiopulmonary bypass. Crit. Care Med. 21, 210–217.PubMedCrossRefGoogle Scholar
  63. 63.
    Miert, A. S., van, and De la Parra, D. A. (1970) Inhibition of gastric emptying by endotoxin (bacterial lipopolysaccharide) in conscious rats and modification of this response by drugs affecting the autonomic nervous system. Arch. Int. Pharmacodyn. Ther. 184, 27–33.Google Scholar
  64. 64.
    Nompleggi, D., Teo, T. C., Blackburn, G. L., and Bistrian, B. R. (1988) Human recombinant interleukin-1 (rIL) decreases gastric emptying in the rat [abstract]. Gastroenterology 94, A326.Google Scholar
  65. 65.
    Tache, Y., Maeda-Hagiwara, M., and Turkelson, C. M. (1987) Central nervous system action of corticotropin-releasing factor to inhibit gastric emptying in rats. Am. J. Physiol. 253, G241 - G245.PubMedGoogle Scholar
  66. 66.
    Fong, Y., Moldawer, L. L., Shires, G. T., and Lowry, S. F. (1990) The biologic characteristics of cytokines and their implication in surgical injury. Surg. Gynecol. Obstet. 170, 363–378.PubMedGoogle Scholar
  67. 67.
    Deitch, E. A. (1990) Intestinal permeability is increased in burn patients shortly after injury. Surgery 107, 411–416.PubMedGoogle Scholar
  68. 68.
    Deitch, E. A. and Bridges, R. M. (1987) Effect of stress and trauma on bacterial translocation from the gut. J. Surg. Res. 42, 536–542.PubMedCrossRefGoogle Scholar
  69. 69.
    Fong, Y. M., Marano, M. A., Barber, A., He, W., Moldawer, L. L., Bushman, E. D., Coyle, S. M., Shires, G. T., and Lowry, S. F. (1989) Total parenteral nutrition and bowel rest modify the metabolic response to endotoxin in human. Ann. Surg. 210, 449–457.PubMedCrossRefGoogle Scholar
  70. 70.
    Patton, J. S., Peters, P. M., McCabe, J., Crase, D., Hansen, S., Chen, A. B., and Liggitt, D. (1987) Development of partial tolerance to the gastrointestinal effects of high doses of recombinant tumor necrosis factor-alpha in rodents. J. Clin. Invest. 80, 1587–1596.PubMedCrossRefGoogle Scholar
  71. 71.
    Gennari, R. and Alexander, J. W. (1995) Anti-interleukin-6 antibody treatment improves survival during gut-derived sepsis in a time-dependent manner by enhancing host defense. Crit. Care Med. 23, 1945–1953.PubMedCrossRefGoogle Scholar
  72. 72.
    Ogle, C. K., Mao, J. X., Wu, J. Z., Ogle, J. D., and Alexander, J. W. (1994) The 1994 Lindberg Award. The production of tumor necrosis factor, interleukin-1, interleukin-6, and prostaglandin E2 by isolated enterocytes and gut macrophages; effect of lipopolysaccharide and thermal injury. J. Burn Care Rehabil. 15, 470–477.PubMedCrossRefGoogle Scholar
  73. 73.
    Langberg, C. W., Hauer-Jensen, M., Sung, C. C., and Kane, C. J. (1994) Expression of fibrogenic cytokines in rat small intestine after fractionated irradiation. Radiother. Oncol. 32, 29–36.PubMedCrossRefGoogle Scholar
  74. 74.
    Murray, F. E., Stinchcombe, S. J., and Hawkey, C. J. (1992) Development of biliary sludge in patients on intensive care unit: Results of a prospective ultrasonographic study. Gut 33, 1123–1125.PubMedCrossRefGoogle Scholar
  75. 75.
    Toler, S. M., Young, B., McClain, C. J., Shedlofsky, S. I., Bandyopadhyay, A. M., and Blouin, R. A. (1993) Head injury and cytochrome P-450 enzymes. Differential effect on mRNA and protein expression in the Fischer-344 rat. Drug Metab. Dispos. 21, 1064–1069.PubMedGoogle Scholar
  76. 76.
    Zagara, G., Vignazia, M., Crespi, G., and Lualdi, M. (1987) Hepatic insufficiency in patients with cranial injuries. Minerva Anestesiol. 53, 559–564.PubMedGoogle Scholar
  77. 77.
    Felver, M. E., Mozey, E., McGuire, M., Mitchell, M. C., Herlong, H. F., Veech, G. A., and Veech, R. L. (1990) Plasma tumor necrosis factor alpha predicts decreased long-term survival in severe alcoholic hepatitis. Alcohol Clin. Exp. Res. 14, 255–259.PubMedCrossRefGoogle Scholar
  78. 78.
    Larrick, J. W. and Wright, S. C. (1990) Cytotoxic mechanism of tumor necrosis factor-alpha. FASEB J. 4, 3215–3223.PubMedGoogle Scholar
  79. 79.
    Shedlofsky, S. I., Swim, A. T., Robinson, J. M., Gallicchio, V. S., Cohen, D. A., and McClain, C. J. (1987) Interleukin-1 (IL-1) depresses cytochrome P450 levels and activities in mice. Life Sci. 40, 2331–2336.PubMedCrossRefGoogle Scholar
  80. 80.
    Stadler, J., Bentz, B. G., Harbrecht, B. G., Di Silvio, M., Curran, R. D., Billiar, T. R., Hoffman, R. A., and Simmons, R. L. (1992) Tumor necrosis factor alpha inhibits hepatocyte mitochondrial respiration. Ann. Surg. 216, 539–546.PubMedCrossRefGoogle Scholar
  81. 81.
    Lewis, J. H. and Zimmerman, H. J. (1984) Bacterial infection as a cause of jaundice. Intern. Med. 5, 94.Google Scholar
  82. 82.
    Utili, R., Abernathy, C. O., and Zimmerman, H. J. (1976) Cholestatic effects of Escherichia coli endotoxin on the isolated perfused rat liver. Gastroenterology 70, 248–253.PubMedGoogle Scholar
  83. 83.
    Utili, R., Abernathy, C. O., and Zimmerman, H. J. (1977) Studies on the effect of E. coli endotoxin on canalicular bile formation in the isolated perfused rat liver. J. Lab. Clin. Med. 89, 471–482.Google Scholar
  84. 84.
    Ott, M. T., Vore, M., Barker, D. E., Strodel, W. E., and McClain, C. J. (1989) Monokine depression of bile flow in the isolated perfused rat liver. J. Surg. Res. 47, 248–250.PubMedCrossRefGoogle Scholar
  85. 85.
    Deaciuc, I. V., Bagby, G. J., Lang, C. H., and Spitzer, J. J. (1993) Hyaluronic acid uptake by the isolated, perfused rat liver: an index of hepatic sinusoidal endothelial cell function. Hepatology 17, 266–272.PubMedCrossRefGoogle Scholar
  86. 86.
    Hennig, B., Honchel, R., Goldblum, S. E., and McClain, C. J. (1988) Tumor necrosis factor-mediated hypoalbuminemia in rabbits. J. Nutr. 118, 1586–1590.PubMedGoogle Scholar
  87. 87.
    Castell, J. V., Gomez-Lehon, M. J., David, M., Hirano, T., Kishimoto, T., and Heinrich, P. C. (1988) Recombinant human interleukin-6 (IL-6/BSF-2/HSF) regulates the synthesis of acute phase proteins in human hepatocytes. FEBS Lett. 232, 347–350.PubMedCrossRefGoogle Scholar
  88. 88.
    Ramadori, G., Van Damme, J., Rieder, H., and Meyer zum Buschenfelde, K. H. (1988) Interleukin 6, the third mediator of acute-phase reaction, modulates hepatic protein synthesis in human and mouse. Comparison with interleukin 1 beta and tumor necrosis factor-alpha. Eur. J. Immunol. 18, 1259–1264.PubMedCrossRefGoogle Scholar
  89. 89.
    Warren, R. S., Starnes, H. F., Jr., Gabrilove, J. L., Oettgen, H. F., and Brennan, M. F. (1987) The acute metabolic effects of tumor necrosis factor administration in humans. Arch. Surg. 122, 1396–1400.PubMedCrossRefGoogle Scholar
  90. 90.
    Proctor, K. G., Falek, R. J., and Capdevilla, J. (1987) Intestinal vasodilation by epoxyeicosatrienoic acids: arachidonic acid metabolites produced by a cytochrome P450 monooxygenase. Circ. Res. 60, 50–59.PubMedCrossRefGoogle Scholar
  91. 91.
    Coon, M. J. and Persson, A. V. (1980) Microsomial cytochrome P-450: A central catalyst in detoxication reactions, in Enzymatic Basis of Detoxification, vol. 1, (Jacoby, W. B., ed.), Academic, New York, pp. 117–134.Google Scholar
  92. 92.
    Nebert, D. W., Nelson, D. R., Adesnick, M., Coon, M. J., Estabrook, R. W., Gonzalez, F. J., Guengerich, F. P., and others. (1989) The P450 superfamily: Updated listing of all genes and recommended nomenclature for the chromosomal loci. DNA 8, 1–13.PubMedCrossRefGoogle Scholar
  93. 93.
    Morgan, E. T. and Norman, C. A. (1990) Pretranslational suppression of cytochrome P-450h (IICl 1) gene expression in rat liver after administration of interferon inducers. Drug. Metab. Dispos. 18, 649–653.PubMedGoogle Scholar
  94. 94.
    Shedlofsky, S. I. and McClain, C. J. (1991) Hepatic dysfunction due to cytokines, in Cytokines and Inflammation ( Kimball, E. S., ed.), CRC, Boca Raton, FL, pp. 235–273.Google Scholar
  95. 95.
    Griffeth, L. K., Rosen, G. M., and Rauchman, E. J. (1987) Effects of model traumatic injury on hepatic drug metabolism in the rat. VI. Major detoxification pathways. Drug Metab. Dispos. 15, 749–759.PubMedGoogle Scholar
  96. 96.
    Fruncillo, R. J. and DiGregorio, G. J. (1983) The effect of thermal injury on drug metabolism in the rat. J. Trauma 23, 523–529.PubMedCrossRefGoogle Scholar
  97. 97.
    Demling, R. and Riessen, R. (1990) Pulmonary dysfunction after cerebral injury. Crit. Care Med. 18, 768–774.PubMedCrossRefGoogle Scholar
  98. 98.
    Simmons, R. L., Martin, A. M., Jr., Heisterkamp, C. A., III, and Ducker, T. B. (1969) Respiratory insufficiency in combat casualties: II. Pulmonary edema following head injury. Ann. Surg. 170, 39–44.PubMedCrossRefGoogle Scholar
  99. 99.
    Simon, R. P. (1983) Neurogenic pulmonary edema. Neurol. Clin. 11, 309–323.Google Scholar
  100. 100.
    Popp, J. A., Shah, D. M., Berman, R. A., Paloski, W. H., Newell, J. C., Cooper, J. A., Rahm, R. L., Gottlieb, M. E., Bourke, R. S., and Malik, A. B. (1982) Delayed pulmonary dysfunction in head-injured patients. J. Neurosurg. 57, 784–790.PubMedCrossRefGoogle Scholar
  101. 101.
    Katsurada, R., Yamada, R., and Sugimoto, T. (1973) Respiratory insufficiency in patients with severe head injury. Surgery 73, 191–199.PubMedGoogle Scholar
  102. 102.
    Bankey, P. E., Williams, J. G., Guice, K. S., and Taylor, S. N. (1995) Interleukin-6 production after thermal injury: evidence for nonmacrophage sources in the lung and liver. Surgery 118, 431–439.PubMedCrossRefGoogle Scholar
  103. 103.
    Mester, M., Carter, E. A., Tompkins, R. J., Gelfand, J. A., Dinarello, J. F., Burke, and Clark, B. D. (1994) Thermal injury induces very early production of interleukin-1 alpha in the rat by mechanisms other than endotoxemia. Surgery 115, 588–596.Google Scholar
  104. 104.
    Goldblum, S. E., Yoneda, K., Cohen, D. A., and McClain, C. J. (1988) Provocation of pulmonary vascular endothelial injury in rabbits by human recombinant interleukin-1 beta. Infect. Immunol. 56, 2255–2263.Google Scholar
  105. 105.
    Gillespie, M. N., Olson, J. W., Hennig, B., Cohen, D. A., McClain, C. J., and Goldblum, S. E. (1989) Monokine-induced lung injury in rats: similarities to monocrotaline-induced pneumotoxicity. Toxicol. Appl. Pharmacol. 98, 134–143.PubMedCrossRefGoogle Scholar
  106. 106.
    Kelley, J. (1990) Cytokines of the lung. Am. Rev. Respir. Dis. 141, 765–788.PubMedCrossRefGoogle Scholar
  107. 107.
    Shepherd, V. L. (1991) Cytokine receptors of the lung. Am. J. Respir. Cell. Mol. Biol. 5, 403–410.PubMedGoogle Scholar
  108. 108.
    Goldblum, S. E., Jay, M., Yoneda, D. A., Cohen, D. A., McClain, C. J., and Gillespie, M. N. (1987) Monokine-induced acute lung injury in rabbits. J. Appl. Physiol. 63, 2093–2100.PubMedGoogle Scholar
  109. 109.
    Palace, G. P., Del Vecchio, P. J., Horgan, M. J., and Malik, A. B. (1993) Release of tumor necrosis factor after pulmonary artery occlusion and reperfusion. Am. Rev. Respir. Dis. 147, 143–147.PubMedCrossRefGoogle Scholar
  110. 110.
    Okusawa, S., Gelfand, J. A., Ikejima, T., Connolly, R. J., and Dinarello, C. A. (1988) Interleukin-1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. J. Clin. Invest. 81, 1162–1172.PubMedCrossRefGoogle Scholar
  111. 111.
    Kunkel, S. L., Standiford, T., Kasahara, K., and Strieter, R. M. (1991) Interleukin-8 (IL-8): the major neutrophil chemotactic factor in the lung. Exp. Lung Res. 17, 17–23.PubMedCrossRefGoogle Scholar
  112. 112.
    Van Zee, K. J., Fischer, E., Hawes, A. S., Hebert, C. A., Terrell, T. G., Baker, J. B., Lowry, S. F., and Moldawer, L. L. (1992) Effects of intravenous IL-8 administration in nonhuman primates. J. Immunol. 148, 1746–1752.Google Scholar
  113. 113.
    Rubin, P., Johnston, C. J., Williams, J. P., McDonald, S., Finkelstein, J. N. (1995) A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis. Int. J. Radiat. Oncol. Biol. Phys. 33, 99–109.PubMedCrossRefGoogle Scholar
  114. 114.
    Baggiolini, M., Dewald, B., and Moser, B. (1994) Interleukin-8 and related chemotactic cytokines—CXC and CC chemokines. Adv. Immunol. 55, 97–179.PubMedCrossRefGoogle Scholar
  115. 115.
    Boylan, A. M., Ruegg, C., Kim, K. J., Hebert, C. A., Hoeffel, J. M., Pytela, R., Sheppard, D., Goldstein, I. M., and Broaddus, V. C. (1992) Evidence of a role for mesothelial cell-derived interleukin-8 in the pathogenesis of asbestos-induced pleurisy in rabbits. J. Clin. Invest. 89, 1257–1267.PubMedCrossRefGoogle Scholar
  116. 116.
    Van Zee, K. J., DeForge, L. A., Fischer, E., Marano, M. A., Kenney, J. S., Remick, D. G., Lowry, S. F., and Moldawer, L. L. (1991) IL-8 in septic shock, endotoxemia, and after IL-1 administration. J. Immunol. 146, 3478–3482.PubMedGoogle Scholar
  117. 117.
    Waage, A. and Espevik, T. (1988) Interleukin 1 potentiates the lethal effect of tumor necrosis factor-alpha/cachectin in mice. J. Exp. Med. 167, 1987–1992.PubMedCrossRefGoogle Scholar
  118. 118.
    Dinarello, C. A., Renfer, L., and Wolff, S. M. (1977) Human leukocyte pyrogen: purification and development of a radioimmunoassay. Proc. Natl. Acad. Sci. USA 74, 4624–4627.PubMedCrossRefGoogle Scholar
  119. 119.
    Watters, J. M., Bessey, P. Q., Dinarello, C. A., Wolff, S. M., and Wilmore, D. W. (1985) The induction of interleukin 1 in humans and its metabolic effects. Surgery 98, 298–306.PubMedGoogle Scholar
  120. 120.
    Bailey, P. T., Abeles, F. B., Hauer, E. C., and Mapes, C. A. (1976) Intracerebroventricular administration of leukocytic endogenous mediators (LEM) in the rat. Proc. Soc. Exp. Biol. Med. 153, 419–423.PubMedGoogle Scholar
  121. 121.
    Beutler, B., Milsark, I. W., and Cerami, A. C. (1985) Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Sicence 229, 869–871.CrossRefGoogle Scholar
  122. 122.
    Lindsey, D. C., Emerson, T. E., Jr., Thompson, T. E., John, A. E., Duerr, M. L., Valdez, C. M., Kuo, H. S., Bouffard, R. B., Irwin, R. G., Canivel, D., and Fournell, M. A. (1991) Characterization of an endotoxemic baboon model of metabolic and organ dysfunction. Circ. Shock 34, 298–310.PubMedGoogle Scholar
  123. 123.
    Schulze-Ostohoff, K., Bakker, A. C., Vanhaesebroeck, B., Beyaert, R., Jacob, W. A., and Fiers, W. (1992) Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation. J. Biol. Chem. 267, 5317–5323.Google Scholar
  124. 124.
    Tracey, K. J., Morgello, S., Koplin, B., Fahey, R. J., III, Fox, J., Aledo, A., Manogue, K. R., Cerami, A., and Fahey, T. J. (1990) Metabolic effects of cachectin/tumor necrosis factor are modified by site of production. Cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexia. J. Clin. Invest. 86, 2014–2024.PubMedCrossRefGoogle Scholar
  125. 125.
    Hoshino, E., Pichard, C., Greenwood, C. E., Kuo, G. C., Cameron, R. G., Kurian, R., Kearns, J. P., Allard, J. P., and Jeejeebhoy, K. N. (1991) Body composition and metabolic rate in rat during a continuous infusion of cachectin. Am. J. Physiol. 260, E27 - E36.PubMedGoogle Scholar
  126. 126.
    Lang, C. H., Dobrescu, C., and Bagby, G. J. (1992) Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology 130, 43–52.PubMedCrossRefGoogle Scholar
  127. 127.
    Matsui, J., Cameron, R. G., Kurian, R., Kuo, G. C., and Jeejeebhoy, K. N. (1993) Nutritional, hepatic, and metabolic effects on cachectin/tumor necrosis factor in rats receiving total parenteral nutrition. Gastroenterology 104, 235–243.PubMedGoogle Scholar
  128. 128.
    Socher, S. H., Friedman, A., and Martinez, D. (1988) Recombinant human tumor necrosis factor induces acute reductions in food intake and body weight in mice. J. Exp. Med. 167, 1957–1962.PubMedCrossRefGoogle Scholar
  129. 129.
    Michie, H. R., Spriggs, D. R., Manogue, K. R., Sherman, M. L., Revhaug, A., O’Dwyer, S. T., Arthur, K., Dinarello, C. A., Cerami, A., Wolff, S. M., Kufe, D. W., and Wilmore, D. W. (1988) Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings. Surgery 104, 280–286.PubMedGoogle Scholar
  130. 130.
    Remick, D. G., Kunkel, R. G., Larrick, J. W., and Kunkel, S. L. (1987) Acute in vivo effects of human recombinant tumor necrosis factor. Lab. Invest. 56, 583–590.PubMedGoogle Scholar
  131. 131.
    Starnes, Jr., H. F., Warren, R. S., Jeevanandam, M., Gabrilove, J. L., Larchian, W., Oettgen, H. F., and Brennan, M. F. (1988) Tumor necrosis factor and the acute metabolic response to tissue injury in man. J. Clin. Invest. 82, 1321–1325.PubMedCrossRefGoogle Scholar
  132. 132.
    Castell, J. V., Andus, T., Kunz, D., and Heinrich, P. C. (1989) Interleukin-6. The major regulator of acute-phase protein synthesis in man and rat. Ann. NY Acad. Sci. 557, 86–101.Google Scholar
  133. 133.
    Bauer, J. and Herrmann, F. (1991) Interleukin-6 in clinical medicine. Ann. Hematol. 62, 203–210.PubMedCrossRefGoogle Scholar
  134. 134.
    Koj, A. (1989) The role of interleukin-6 as the hepatocyte stimulating factor in the network of inflammatory cytokines. Ann. NYAcad. Sci. 557, 1–8.CrossRefGoogle Scholar
  135. 135.
    Kishimoto, T. (1989) The biology of interleukin-6. Blood 74, 1–10.PubMedGoogle Scholar
  136. 136.
    Nijsten, M. W., de Groot, E. R., ten Duis, H. J., Klasen, H. J., Hack, C. E., and Aarden, L. A. (1987) Serum levels of interleukin-6 and acute phase responses [letter]. Lancet 2, 921.PubMedCrossRefGoogle Scholar
  137. 137.
    De Simoni, M. G., Sironi, M., De Luigi, A., Manfridi, A., Mantovani, A., and Ghezzi, P. (1990) Intracerebroventricular injection of interleukin 1 induces high circulating levels of interleukin 6. J. Exp. Med. 171, 1773–1778.PubMedCrossRefGoogle Scholar
  138. 138.
    Okusawa, S., Gelfand, J. A., Ikejima, T., Connolly, R. J., and Dinarello, C. A. (1988) Interleukin-1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. J. Clin. Invest. 81, 1162–1172.PubMedCrossRefGoogle Scholar
  139. 139.
    Mukaida, N. and Matsushima, K. (1992) Regulation of IL-8 production and the characteristics of the receptors for IL-8. Cytokines 4, 41–53.PubMedGoogle Scholar
  140. 140.
    Van Zee, K. J., DeForge, L. E., Fischer, E., Marano, M. A., Kenney, J. S., Remick, D. G., Lowry, S. F., and Moldawer, L. L. (1991) IL-8 in septic shock, endotoxemia, and after IL-1 administration. J. Immunol. 146, 3478–3482.PubMedGoogle Scholar
  141. 141.
    Sheron, N. and Williams, R. (1992) IL-8 as a circulating cytokine: induction by recombinant tumor necrosis factor-alpha. Clin. Exp. Immunol. 89, 100–103.PubMedCrossRefGoogle Scholar
  142. 142.
    Leonard, E. J., Yoshimura, T., Tanaka, S., and Raffeld, M. (1991) Neutrophil recruitment by intradermally injected neutrophil attractant/activation protein-1. J. Invest. Dermatol. 96, 690–694.PubMedCrossRefGoogle Scholar
  143. 143.
    Fong, Y., Tracey, K. J., Moldawer, L. L., Hesse, D. G., Manogue, K. B., Kenney, J. S., Lee, A. T., Kuo, G. G., Allison, A. C., Lowry, S. F., and Cerami, A. (1989) Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia. J. Exp. Med. 170, 1627–1633.PubMedCrossRefGoogle Scholar
  144. 144.
    Mulligan, M. S., Jones, M. L., Bolanowski, M. A., Baganoff, M. P., Deppeler, C. L., Meyers, D. M., Ryan, U. S., and Ward, P. A. (1993) Inhibition of lung inflammatory reactions in rats by an anti-human IL-8 antibody. J. Immunol. 150, 5585–5595.PubMedGoogle Scholar
  145. 145.
    Balkwill, F., Osborne, R., Burke, F., Naylor, S., Talbot, D., Durbin, H., Tavernier, J., Fiers, W. (1987) Evidence for tumor necrosis factor/cachectin production in cancer. Lancet 2, 1229–1232.PubMedCrossRefGoogle Scholar
  146. 146.
    Rodriguez, J. L., Miller, C. G., Garner, W. L., Till, G. O., Guerrero, P., Moore, N. P., Corridore, M., Normolle, D. P., Smith, D. J., and Remick, D. G. (1993) Correlation of the local and systemic cytokine response with clinical outcome following thermal injury. J. Trauma 34, 684–695.PubMedCrossRefGoogle Scholar
  147. 147.
    Miller, E. J., Cohen, A. B., Nagao, S., Griffith, D., Maunder, R. J., Martin, T. R., Weiner-Kronish, J. P., Sticherling, M., Christophers, E., and Matthay, M. A. (1992) Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am. Rev. Respir. Dis. 146, 427–432.PubMedGoogle Scholar
  148. 148.
    Rodrick, M. L., Wood, J. J., Grbic, J. T., O’Mahoney, J. B., Davis, C. F., Moss, N. M., Blazar, B. A., Demling, R. H., Mannick, J. A. (1986) Defective IL-2 production in patients with severe burns and sepsis. Lymphokine Res. 5, S75 - S80.PubMedGoogle Scholar
  149. 149.
    Wogensen, L., Jensen, M., Svensson, P., Worsaae, H., Welinder, B., and Nerup, J. (1993) Pancreatic beta-cell function and interleukin-1 beta in plasma during the acute phase response in patients with major burn injuries. Eur. J. Clin. Invest. 23, 311–319.PubMedCrossRefGoogle Scholar
  150. 150.
    Ohzato, H., Monden, M., Yoshizaki, K., Ogata, A., Nishimoto, N., Gotoh, M., Kishimoto, T., and Mori, T. (1993) Systemic production of interleukin-6 following acute inflammation. Biochem. Biophys. Res. Commun. 197, 1556–1562.PubMedCrossRefGoogle Scholar
  151. 151.
    Marano, M. A., Fong, Y., Moldawer, L. L., Wei, H., Calvano, S. E., Tracey, K. J., Barie, P. S., Manogue, K., Cerami, A., Shires, G. T., Lowry, S. F. (1990) Serum cachectin/tumor necrosis factor in critically ill patients with burns correlates with infection and mortality. Surg. Gynecol. Obstet. 170, 32–38.PubMedGoogle Scholar
  152. 152.
    Nawata, Y., Eugui, E. M., Lee, S. W., and Allison, A. C. (1989) IL-6 is the principal factor produced by synovia of patients with rheumatoid arthritis that induces B lymphocytes to secrete immunoglobulin Ann. NY Acad. Sci. 557, 230–239.PubMedCrossRefGoogle Scholar
  153. 153.
    Roche, N. E., Fulbright, J. W., Wagner, A. D., Hunder, G. G., Goronzy, J. J., and Weyand, C. M. (1993) Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis. Arthritis Rheum. 36, 1286–1294.PubMedCrossRefGoogle Scholar
  154. 154.
    Waage, A., Halstensen, A., and Espevik, T. (1987) Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1, 355–357.PubMedCrossRefGoogle Scholar
  155. 155.
    Waage, A. Brandtzaeg, P., Halstensen, A., Kierulf, P., and Espevik, T. (1989) The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J. Exp. Med. 169, 333–338.PubMedCrossRefGoogle Scholar
  156. 156.
    Endo, S., Inada, K., Kasai, T., Takakuwa, T., Nakae, H., Kikuchi, M., Yamashita, H., and Yoshida, M. (1994) Soluble CD14 (sCD14) levels in patients with multiple organ failure (MOF). Res. Commun. Chem. Pathol. Pharmacol. 84, 17–25.PubMedGoogle Scholar
  157. 157.
    Liu, X. S., Luo, Z. H., Yang, Z. C., Huang, W. H., and Li, A. N. (1994) The significance of changes in serum tumour necrosis factor (TNF) activity in severely burned patients. Burns 20, 40–44.PubMedCrossRefGoogle Scholar
  158. 158.
    Cannon, J. G., Tompkins, R. G., Gelfand, J. A., Michie, H. R., Standord, C. G., van der Meer, J. W., Endres, S., Lonnemann, G., Corsetti, J., Chernow, B., Wilmore, D. W., Wolff, S. M., Burke, J. F., and Dinarello, C. A. (1990) Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J. Infect. Dis. 161, 79–84.PubMedCrossRefGoogle Scholar
  159. 159.
    Schindler, R., Clark, B. D., and Dinarello, C. A. (1990) Dissociation between interleukin-1 beta mRNA and protein synthesis in human peripheral blood mononuclear cells. J. Biol. Chem. 265, 10232–10237.PubMedGoogle Scholar
  160. 160.
    Knudsen, P. J., Dinarello, C. A., and Strom, T. B. (1986) Prostaglandins posttranscriptionally inhibit monocyte expression of interleukin 1 activity by increasing intracellular cyclic adenosine monophosphate. J. Immunol. 137, 3189–3194.PubMedGoogle Scholar
  161. 161.
    Hurme, M. (1990) Modulation of interleukin-1 beta production by cyclic AMP in human monocytes. FEBS Lett. 263, 35–37.PubMedCrossRefGoogle Scholar
  162. 162.
    Vannier, E., Miller, L. C., Schindler, R., Terlain, B., and Dinarello, C. A. (1989) Histamine suppressed the synthesis of tumor necrosis factor-alpha in vitro via H2 receptors [abstract]. Cytokine 1, 123.Google Scholar
  163. 163.
    Endres, S., Fulle, H. J., Sinha, B., Stoll, D., Dinarello, C. A., Gerzer, R., and Weber, P. D. (1991) Cyclic nucleotides differently regulate the synthesis of tumour necrosis factor-alpha and interleukin-1 beta by human mononuclear cells. Immunology 72, 56–60.PubMedGoogle Scholar
  164. 164.
    Chao, C. C., Hu, S., Close, K., Choi, C. S., Molitor, R. W., Novick, W. J., and Peterson, P. K. (1992) Cytokine release from microglia: differential inhibition by pentoxifylline and dexamethasone. J. Infect. Dis. 166, 847–853.PubMedCrossRefGoogle Scholar
  165. 165.
    Ziegler, E. J., Fisher, C. J., Sprung, C. L., Straube, R. C., Sadoff, J. C., Foulke, G. E., Wortel, C. H., Fink, M. P., Dellinger, P., Teng, N. N., Allen, I. E., Berger, H. J., Knatterud, G. L., LoBuglio, A. F., Smith, C. R., and the HA-1A Sepsis Study Group. (1991) Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. N. Engl. J. Med. 324, 429–436.CrossRefGoogle Scholar
  166. 166.
    Endres, S., Ghorbani, R., Kelley, V. E., Georgilis, K., Lonnemann, G., van der Meer, J. W., Cannon, J. G., Rogers, T., Klempner, M. S., Weber, P. C., Schaefer, E. J., Wolff, S. M., and Dinarelli, C. A. (1989) The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N. Engl. J. Med. 320, 265–271.PubMedCrossRefGoogle Scholar
  167. 167.
    Meydani, S. N., Endres, S., Woods, M. M., Goldin, B. R., Soo, C., Morrill-Labrode, A., Dinarello, C., and Gorbach, S. L. (1991) Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparision between young and older women. J. Nutr. 121, 547–555.PubMedGoogle Scholar
  168. 168.
    Eugui, E., Delustro, B., Rouhafza, S., Wilhelm, R., and Allison, A. C. (1993) Coordinate inhibition by some antioxidants of TNF alpha, IL-1 beta, and IL-6 production by human peripheral blood mononuclear cells. Ann. NY Acad. Sci. 696, 171–184.PubMedCrossRefGoogle Scholar
  169. 169.
    Gastinne, H., Wolff, M., Delatour, F., Faurisson, F., and Chevret, S. (1992) A controlled trial in intensive care units of selective decontamination of the digestive tract with nonabsorbable antibiotics. The French Study Group on Selective Decontamination of the Digestive Tract. N. Engl. J. Med. 326, 594–599.PubMedCrossRefGoogle Scholar
  170. 170.
    Soube, W. W., Klimberg, V. S., Plumley, D. A., Salloum, R. M., Flynn, T. C., Bland, K. I., and Copeland, E. M., III (1990) The role of glutamine in maintaining a healthy gut and supporting the metabolic response to injury and infection. J. Surg. Res. 48, 383–391.CrossRefGoogle Scholar
  171. 171.
    Alexander, J. W. (1993) Immunoenhancement via enteral nutrition. Arch. Surg. 128, 1242–1245.PubMedCrossRefGoogle Scholar
  172. 172.
    Nagaki, M., Hughes, R. D., Lau, J. Y., and Williams, R. (1991) Removal of endotoxin and cytokines by adsorbents and the effect of plasma protein binding. Int. J. Artif. Organs 14, 43–50.PubMedGoogle Scholar
  173. 173.
    Bysani, G., Shenep, J. L., Hildner, W. K., Stidham, G. L., and Roberson, P. K. (1990) Detoxification of plasma containing lipopolysaccharide by adsorption. Crit. Care Med. 18, 67–71.PubMedCrossRefGoogle Scholar
  174. 174.
    Goss, J. R., Styren, S. D., Miller, P. D., Kochanek, P. M., Palmer, A. M., Marion, D. W., and DeKosky, S. T. (1995) Hypothermia attenuates the normal increase in interleukin 1 beta RNA and nerve growth factor following traumatic brain injury in the rat. J. Neurotrauma 12, 159–167.CrossRefGoogle Scholar
  175. 175.
    Tracey, K. J., Fong, Y., Hesse, D. G., Manogue, K. R., Lee, A. T., Kuo, G. C., Lowry, S. F., and Cerami, A. (1987) Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330, 662–664.PubMedCrossRefGoogle Scholar
  176. 176.
    Mathison, J. C., Wolfson, E., and Ulevitch, R. J. (1988) Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharideinduced injury in rabbits. J. Clin. Invest. 81, 1925–1937.PubMedCrossRefGoogle Scholar
  177. 177.
    Yim, J. H., Tewari, A., Pearce, M. K., Zou, J. C., Abrams, J. S., and Starnes, H. F., Jr. (1990) Monoclonal antibody against murine interleukin-6 prevents lethal effects of Escherichia coli sepsis and tumor necrosis factor challenge in mice. Surg. Forum 41, 114–117.Google Scholar
  178. 178.
    Seckinger, P. and Dayer, J. M. (1987) Interleukin-1 inhibitors. Ann. Inst. Pasteur Immunol. 138, 486–488.PubMedCrossRefGoogle Scholar
  179. 179.
    Mazzei, G. J., Seckinger, P. L., Dayer, J. M., and Shaw, A. R. (1990) Purification and characterization of a 26-kDa competitive inhibitor of interleukin 1. Eur. J. Immunol. 20, 683–689.PubMedCrossRefGoogle Scholar
  180. 180.
    Dinarello, C. A., Rosenwasser, L. J., and Wolff, S. M. (1981) Demonstration of a circulating suppressor factor of thymocyte proliferation during endotoxin fever in humans. J. Immunol. 127, 2517–2519.PubMedGoogle Scholar
  181. 181.
    Liao, Z., Grimshaw, R. S., and Rosenstreich, D. L. (1984) Identification of a specific interleukin-1 inhibitor in the urine of febrile patients. J. Exp. Med. 159, 126–136.PubMedCrossRefGoogle Scholar
  182. 182.
    Eisenberg, S. P., Evans, R. J., Arend, W. P., Verderber, E., Brewer, M. T., Hannum, C. H., and Thompson, R. C. (1990) Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 343, 341–346.PubMedCrossRefGoogle Scholar
  183. 183.
    Hannum, C. H., Wilcox, C. J., Arend, W. P., Joslin, F. G., Dripps, D. J., Heimdal, P. L., Armes, L. G., Sommer, A., Eisenberg, S. P., and Thompson, R. C. (1990) Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 343, 336–340.PubMedCrossRefGoogle Scholar
  184. 184.
    Carter, D. B., Deibel, M. R., Jr., Dunn, C. J., Tomich, C. S., Laborde, A. L., Slightom, J. L., Berger, A. E., Bienkowski, M. J., Sun, F. F., McEwan, R. N., Harris, P. K., Yem, A. W., Waszak, G. A., Chosay, J. G., Sieu, L. C., Hardee, M. M., Zurcher-Neely, H. A., Reardon, I. M., Heinrikson, R. L., Tuesdall, S. E., Shelly, J. A., Eessalu, T. E., Taylor, B. M., and Tracey, D. E. (1990) Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein. Nature 344, 633–638.PubMedCrossRefGoogle Scholar
  185. 185.
    Ohlsson, K., Bjork, P., Bergenfeldt, M., Hageman, R., and Thompson, R. C. (1990) Interleukin 1 receptor antagonist reduces mortality from endotoxin shock. Nature 347, 550–552.CrossRefGoogle Scholar
  186. 186.
    Cominelli, F., Nast, C. C., Clark, B. D., Schindler, R., Lierena, R., Eysselein, V. E., Thompson, R. C., and Dinarello, C. A. (1990) Interleukin-1 gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis. J. Clin. Invest. 86, 972–980.PubMedCrossRefGoogle Scholar
  187. 187.
    Cominelli, F., Llerena, F., Clark, B. D., Nast, C. C., Thompson, R. C., and Dinarello, C. A. (1990) In vivo antiinflammatory properties of recombinant interleukin-1 receptor antagonist (IL-1ra) [abstract]. Lymph. Res. 9, 597.Google Scholar
  188. 188.
    Ramilo, O., Saez-Llorens, X., Mertsola, J., Jafari, H., Olsen, K. D., Hansen, E. J., Yoshinaga, M., Ohkawara, S., Nariuchi, H., and McCraken, G. H., Jr. (1990) Tumor necrosis factor alpha/cachectin and interleukin-1 beta initiate meningeal inflammation. J. Exp. Med. 172, 497–507.PubMedCrossRefGoogle Scholar
  189. 189.
    Opp, M. R. and Krueger, J. M. (1991) Human interleukin 1-receptor antagonist blocks interleukin 1-induced sleep and fever. Am. J. Physiol. 260, R453 - R457.PubMedGoogle Scholar
  190. 190.
    Gershenwald, J. E., Fong, Y., Fahey, T. J., III, Calvano, S. E., Chizzonite, R., Kilian, P. L., Lowry, S. F., and Moldawer, L. L. (1990) Interleukin 1 receptor blockage attenuates the host inflammatory response. Proc. Natl. Acad. Sci. USA 87, 4966–4970.PubMedCrossRefGoogle Scholar
  191. 191.
    Giroir, B. P., Horton, J. W., White, D. J., McIntyre, K. L., and Lin, C. Q. (1994) Inhibition of tumor necrosis factor prevents myocardial dysfunction during burn shock. Am. J. Physiol. 267, H118 - H124.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Linda Ott
  • Craig McClain
  • Stephen Scheff
  • Jimmi Hatton
  • Byron Young

There are no affiliations available

Personalised recommendations